Candriam SCA’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$695K Hold
2021
Q4
$1.91M Hold
2021
Q3
$2.61M Hold
2021
Q2
$3.18M Buy
2019
Q4
Sell
2019
Q3
$1.75M Hold
2019
Q2
$1.56M Sell
2019
Q1
$1.86M Hold
2018
Q4
$1.14M Hold
2018
Q3
$2.43M Hold
2018
Q2
$2.08M Hold
2018
Q1
$2.65M Sell
2017
Q4
$2.04M Buy
2017
Q3
$1.77M Buy